Found: 32
Select item for more details and to access through your institution.
Expression of protectin (CD59) in human melanoma and its functional role in cell- and complement-mediated cytotoxicity.
- Published in:
- International Journal of Cancer, 1995, v. 61, n. 4, p. 548, doi. 10.1002/ijc.2910610420
- By:
- Publication type:
- Article
Thymosin α1 in melanoma: from the clinical trial setting to the daily practice and beyond.
- Published in:
- Annals of the New York Academy of Sciences, 2012, v. 1270, n. 1, p. 8, doi. 10.1111/j.1749-6632.2012.06757.x
- By:
- Publication type:
- Article
'Cancer Bio-Immunotherapy in Siena': Thirteenth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 8-10, 2015.
- Published in:
- 2016
- By:
- Publication type:
- Report
'Cancer Bio-Immunotherapy in Siena': Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014.
- Published in:
- 2016
- By:
- Publication type:
- Report
' Cancer Bio-Immunotherapy in Siena': Eleventh Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 17-19, 2013.
- Published in:
- 2015
- By:
- Publication type:
- Report
Tenth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), SIENA, Italy, November 5–7, 2012.
- Published in:
- 2013
- By:
- Publication type:
- Report
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 6, p. 1021, doi. 10.1007/s00262-013-1418-6
- By:
- Publication type:
- Article
Ninth annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, Italy, October 19-22, 2011: New perspectives in the immunotherapy of cancer.
- Published in:
- 2012
- By:
- Publication type:
- Report
Eighth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, October 7-9, 2010.
- Published in:
- 2011
- By:
- Publication type:
- Report
Seventh annual meeting of the Italian Network for Tumor Biotherapy (NIBIT), Siena, 1-3 October 2009.
- Published in:
- 2010
- By:
- Publication type:
- Proceeding
Sixth annual meeting of the Italian network for tumor biotherapy (NIBIT), Siena, 16–18 October 2008.
- Published in:
- 2010
- By:
- Publication type:
- Proceeding
Vaccination of Stage IV patients with allogeneic IL-4- or IL-2-gene-transduced melanoma cells generates functional antibodies against vaccinating and autologous melanoma cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2002, v. 51, n. 1, p. 9, doi. 10.1007/s00262-001-0249-z
- By:
- Publication type:
- Article
Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels.
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6557, doi. 10.1038/sj.onc.1206813
- By:
- Publication type:
- Article
Targeted therapy of solid malignancies via HLA class II antigens: a new biotherapeutic approach?
- Published in:
- Oncogene, 2003, v. 22, n. 42, p. 6564, doi. 10.1038/sj.onc.1206960
- By:
- Publication type:
- Article
Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours.
- Published in:
- Cardiovascular Research, 2010, v. 86, n. 1, p. 12, doi. 10.1093/cvr/cvp332
- By:
- Publication type:
- Article
Is it the primetime for endoglin (CD105) in the clinical setting?
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Methylation-regulated expression of HLA class I antigens in melanoma.
- Published in:
- International Journal of Cancer, 2003, v. 105, n. 3, p. 430, doi. 10.1002/ijc.11077
- By:
- Publication type:
- Article
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-202
- By:
- Publication type:
- Article
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The Italian Network for Tumor Biotherapy (NIBIT): Getting together to push the field forward.
- Published in:
- 2008
- By:
- Publication type:
- Editorial
Optimizing complement-activating antibody-based cancer immunotherapy: a feasible strategy?
- Published in:
- Journal of Translational Medicine, 2004, v. 2, p. 1
- By:
- Publication type:
- Article
Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer.
- Published in:
- Journal of Translational Medicine, 2004, v. 2, p. 18, doi. 10.1186/1479-5876-2-18
- By:
- Publication type:
- Article
Expression and regulation of B7-H3 immunoregulatory receptor, in human mesothelial and mesothelioma cells: Immunotherapeutic implications.
- Published in:
- Journal of Cellular Physiology, 2011, v. 226, n. 10, p. 2595, doi. 10.1002/jcp.22600
- By:
- Publication type:
- Article
Epigenetically regulated clonal heritability of CTA expression profiles in human melanoma.
- Published in:
- Journal of Cellular Physiology, 2010, v. 223, n. 2, p. 352, doi. 10.1002/jcp.22040
- By:
- Publication type:
- Article
Epigenetic drugs as pleiotropic agents in cancer treatment: Biomolecular aspects and clinical applications.
- Published in:
- Journal of Cellular Physiology, 2007, v. 212, n. 2, p. 330, doi. 10.1002/jcp.21066
- By:
- Publication type:
- Article
Phenotypic and functional changes of human melanoma xenografts induced by DNA hypomethylation: Immunotherapeutic implications.
- Published in:
- Journal of Cellular Physiology, 2006, v. 207, n. 1, p. 58, doi. 10.1002/jcp.20540
- By:
- Publication type:
- Article
Methylation‐regulated expression of cancer testis antigens in primary effusion lymphoma: Immunotherapeutic implications L. Calabrò and E. Fonsatti contributed equally to this work.
- Published in:
- Journal of Cellular Physiology, 2005, v. 202, n. 2, p. 474, doi. 10.1002/jcp.20133
- By:
- Publication type:
- Article
Targeting of HLA-DR molecules transduces agonistic functional signals in cutaneous melanoma (This study is dedicated to the memory of Raffaele Tecce.).
- Published in:
- Journal of Cellular Physiology, 2004, v. 200, n. 2, p. 272, doi. 10.1002/jcp.20015
- By:
- Publication type:
- Article
Differential levels of soluble endoglin (CD105) in myeloid malignancies.
- Published in:
- Journal of Cellular Physiology, 2003, v. 194, n. 2, p. 171, doi. 10.1002/jcp.10200
- By:
- Publication type:
- Article
Recombinant transmembrane CD59 (CD59-TM) confers complement resistance to GPI-anchored protein defective melanoma cells.
- Published in:
- Journal of Cellular Physiology, 2002, v. 190, n. 2, p. 200, doi. 10.1002/jcp.10050
- By:
- Publication type:
- Article
Endoglin: An accessory component of the TGF-β-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies.
- Published in:
- Journal of Cellular Physiology, 2001, v. 188, n. 1, p. 1, doi. 10.1002/jcp.1095
- By:
- Publication type:
- Article
Overexpression of protectin (CD59) down-modulates the susceptibility of human melanoma cells to homologous complement.
- Published in:
- Journal of Cellular Physiology, 2000, v. 185, n. 3, p. 317, doi. 10.1002/1097-4652(200012)185:3<317::AID-JCP1>3.0.CO;2-L
- By:
- Publication type:
- Article